(Q33594429)

28 July 2017

1 reference

title

Neuroactive steroids: potential therapeutic use in neurological and psychiatric disorders (English)

1 reference

28 July 2017

Gasior M

1

1 reference

PubMed ID

10203866

28 July 2017

Carter RB

series ordinal

2

1 reference

PubMed ID

10203866

28 July 2017

Witkin JM

series ordinal

3

1 reference

28 July 2017

1 March 1999

1 reference

Trends in Pharmacological Sciences

28 July 2017

1 reference

28 July 2017

20

1 reference

28 July 2017

107-112

1 reference

28 July 2017

3

1 reference

Neurosteroids and GABAA receptor function.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The neuropsychopharmacological potential of neuroactive steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Does antiepileptic drug therapy prevent the development of "chronic" epilepsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anxiolytic activity of an endogenous adrenal steroid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Comparative behavioral characterization of the neuroactive steroids 3 alpha-OH,5 alpha-pregnan-20-one and 3 alpha-OH,5 beta-pregnan-20-one in rodents.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anxiolytic effects of 3α-hydroxy-5α[β]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allopregnanolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Sleep induction by an adrenal steroid in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

GABAA-receptor-mediated effects of progesterone, its ring-A-reduced metabolites and synthetic neuroactive steroids on neurogenic oedema in the rat meninges

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The neurosteroid, 3 alpha-hydroxy-5 alpha-pregnan-20-one, protects against bicuculline-induced seizures during ethanol withdrawal in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Neuroactive steroid sensitivity in withdrawal seizure-prone and -resistant mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Neurosteroids and the naloxone-precipitated withdrawal syndrome in morphine-dependent mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The neurosteroid 3 alpha, 5 apha-THP has antiseizure and possible neuroprotective effects in an animal model of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Development and regeneration of the nervous system: a role for neurosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Anxiolytic and anticonvulsant activity of a synthetic neuroactive steroid Co 3-0593.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Role of tyrosine kinase pathways in ETB receptor activation of NHE3.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

The anaesthetic action and modulation of GABAA receptor activity by the novel water-soluble aminosteroid Org 20599.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Double-blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Prophylactic treatment of migraine with flumedroxone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Headache recurrence in pregnant women with migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Animal models of drug withdrawal symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Development of tolerance in mice to the sedative effects of the neuroactive steroid minaxolone following chronic exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Positive allosteric modulators of the GABA(A) receptor: differential interaction of benzodiazepines and neuroactive steroids with ethanol.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

Rewarding effect of the neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2899%2901318-8

7 January 2021

10.1016/S0165-6147(99)01318-8

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10203866